Related references
Note: Only part of the references are listed.IL-22 is related to development of human colon cancer by activation of STAT3
Runqiu Jiang et al.
BMC CANCER (2013)
Interleukin-11 Is the Dominant IL-6 Family Cytokine during Gastrointestinal Tumorigenesis and Can Be Targeted Therapeutically
Tracy L. Putoczki et al.
CANCER CELL (2013)
Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model
Stefanie Kirchberger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Role of IL-17A in the development of colitis-associated cancer
Yil Sik Hyun et al.
CARCINOGENESIS (2012)
Healing of intestinal inflammation by IL-22
Atsushi Mizoguchi
INFLAMMATORY BOWEL DISEASES (2012)
Interleukin-6-A Key Regulator of Colorectal Cancer Development
Maximilian J. Waldner et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
The Dual Role of Inflammation in Colon Carcinogenesis
Giovanni Monteleone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber et al.
NATURE (2012)
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov et al.
NATURE (2012)
A Protective Role by Interleukin-17F in Colon Tumorigenesis
Zan Tong et al.
PLOS ONE (2012)
IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence
Guanglin Cui et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)
Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Nichole R. Blatner et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Human Th17 cells in patients with cancer Friends or foe?
Tim F. Greten et al.
ONCOIMMUNOLOGY (2012)
Interleukin-21 in cancer immunotherapy Friend or foe?
Carmine Stolfi et al.
ONCOIMMUNOLOGY (2012)
The split nature of tumor-infiltrating leukocytes Implications for cancer surveillance and immunotherapy
Telma Lanca et al.
ONCOIMMUNOLOGY (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma
Jiankun Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
Wolf Herman Fridman et al.
CANCER RESEARCH (2011)
Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer
Marie Tosolini et al.
CANCER RESEARCH (2011)
Th17 cells in cancer: help or hindrance?
Cailin Moira Wilke et al.
CARCINOGENESIS (2011)
Interleukin 21 controls tumour growth and tumour immunosurveillance in colitis-associated tumorigenesis in mice
Dominik Jauch et al.
GUT (2011)
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer
Carmine Stolfi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interleukin-22 genetic polymorphisms and risk of colon cancer
Cheryl L. Thompson et al.
CANCER CAUSES & CONTROL (2010)
Interleukin-22: A cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection
Ellen Witte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Interleukin-26: An IL-10-related cytokine produced by Th17 cells
Raymond P. Donnelly et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Inflammation and Colon Cancer
Janos Terzic et al.
GASTROENTEROLOGY (2010)
Effector T cell plasticity: flexibility in the face of changing circumstances
Kenneth M. Murphy et al.
NATURE IMMUNOLOGY (2010)
Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Wook-Jin Chae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Endogenous IL-17 contributes to reduced tumor growth and metastasis
Ilona Kryczek et al.
BLOOD (2009)
Worldwide Variations in Colorectal Cancer
Melissa M. Center et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
Sergei Grivennikov et al.
CANCER CELL (2009)
Developmental plasticity of Th17 and Treg cells
Yun Kyung Lee et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
Shaoguang Wu et al.
NATURE MEDICINE (2009)
Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells.
Pierre Miossec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
IL-21: roles in immunopathology and cancer therapy
H. Sondergaard et al.
TISSUE ANTIGENS (2009)
Interleukin-21 as a new therapeutic target for immune-mediated diseases
Giovanni Monteleone et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Interleukin-6 and cachexia in ApcMin/+ mice
Kristen A. Baltgalvis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Interleukin-21: Basic biology and implications for cancer and autoimmunity
Rosanne Spolski et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Regulation of gut inflammation and Th17 cell response by interleukin-21
Daniele Fina et al.
GASTROENTEROLOGY (2008)
T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma
Xuexian O. Yang et al.
IMMUNITY (2008)
IL-21 and TGF-β are required for differentiation of human TH17 cells
Li Yang et al.
NATURE (2008)
Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17-producing T cells
Fuping Zhang et al.
NATURE IMMUNOLOGY (2008)
Th17 cells: Effector T cells with inflammatory properties
Thomas Korn et al.
SEMINARS IN IMMUNOLOGY (2007)
Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation
Takao Hinoi et al.
CANCER RESEARCH (2007)
Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells
Eva V. Acosta-Rodriguez et al.
NATURE IMMUNOLOGY (2007)
IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways
Liang Zhou et al.
NATURE IMMUNOLOGY (2007)
The interleukin-22/STAT3 pathway potentiates expression of inducible nitric-oxide synthase in human colon carcinoma cells
Elisabeth Ziesche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells
Ivaylo I. Ivanov et al.
CELL (2006)
Interleukin-21 enhances T-helper cell type 1 signaling and interferon-γ production in Crohn's disease
G Monteleone et al.
GASTROENTEROLOGY (2005)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
Cloning and characterization of mouse IL-22 binding protein
CC Wei et al.
GENES AND IMMUNITY (2003)
Interleukin-17 promotes angiogenesis and tumor growth
M Numasaki et al.
BLOOD (2003)
Interleukin-17 family and IL-17 receptors
TA Moseley et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line - Pathways that are shared with and distinct from IL-10
D Lejeune et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cutting edge: IL-17F, a novel cytokine selectively expressed in activated T cells and monocytes, regulates angiogenesis and endothelial cell cytokine production
T Starnes et al.
JOURNAL OF IMMUNOLOGY (2001)
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity
SV Kotenko et al.
JOURNAL OF IMMUNOLOGY (2001)
Cloning and characterization of IL-22 binding protein, a natural antagonist of IL-10-related T cell-derived inducible factor/IL-22
L Dumoutier et al.
JOURNAL OF IMMUNOLOGY (2001)
The risk of colorectal cancer in ulcerative colitis: a meta-analysis
JA Eaden et al.
GUT (2001)
Share Paper
